Biostar Pharmaceuticals Inc  

(Public, NASDAQ:BSPM)   Watch this stock  
Find more results for BSPM
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.05 - 3.49
Open     -
Vol / Avg. 0.00/99,406.00
Mkt cap 18.57M
P/E 6.50
Div/yield     -
EPS 0.18
Shares 15.48M
Beta 2.67
Inst. own 5%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 1.64% 1.53%
Operating margin 1.25% 0.96%
EBITD margin - 6.70%
Return on average assets 1.23% 1.17%
Return on average equity 1.40% 1.34%
Employees 438 -
CDP Score - -


No. 588 Shiji Xi Avenue
+86-29-33686638 (Phone)
+86-29-33685386 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its wholly owned subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar) and its variable interest entity (VIE) Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical), develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People�s Republic of China. The Company's product is the Xin Ao Xing Oleanolic Acid Capsule, an over-the- counter (OTC) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. As of December 31, 2011, the Company�s product line also includes five other OTC products, 10 prescription-based pharmaceuticals, five nutriceuticals or health products and one medical device. On October 25, 2011, the Company completed the acquisition of Shaanxi Weinan Huaren Pharmaceuticals, Ltd (Shaanxi Weinan).

Officers and directors

Ronghua Wang Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Qinghua Liu Interim Chief Financial Officer, Director
Age: 46
Bio & Compensation  - Reuters
Zhenghong Wang Chief Operating Officer
Age: 33
Bio & Compensation  - Reuters
Shuang Gong Secretary of Board
Age: 46
Bio & Compensation  - Reuters
King Fai Leung Independent Director
Age: 41
Bio & Compensation  - Reuters
Zhongyang Shang Independent Director
Age: 62
Bio & Compensation  - Reuters
Haipeng Wu Independent Director
Age: 56
Bio & Compensation  - Reuters